Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xvivo Perfusion AB (XVIPF)
OTHER OTC:XVIPF
Holding XVIPF?
Track your performance easily
XVIPF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$19.50 - $48.04
Previous Close$47.85
Volume240.00
Average Volume (3M)234.00
Market Cap
$1.54B
Enterprise Value$1.54B
Total Cash (Recent Filing)kr197.95M
Total Debt (Recent Filing)kr292.99M
Price to Earnings (P/E)132.5
Beta1.41
Next Earnings
Oct 24, 2024EPS Estimate
$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.36
Shares Outstanding31,499,470
10 Day Avg. Volume128
30 Day Avg. Volume234
Standard Deviation0.18
R-Squared0.00737
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$45.03Price Target Upside-7.06% Downside
Rating ConsensusHold
Number of Analyst Covering1
Xvivo Perfusion AB News
PremiumPre-Earnings
Is XVIPF a Buy, Before Earnings?
PremiumPre-Earnings
Is XVIPF a Buy, Before Earnings?
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
4.70% Mutual Funds
1.25% Other Institutional Investors
94.05% Public Companies and
Individual Investors
XVIPF FAQ
What was Xvivo Perfusion AB’s price range in the past 12 months?
Xvivo Perfusion AB lowest stock price was $19.50 and its highest was $48.04 in the past 12 months.
What is Xvivo Perfusion AB’s market cap?
Currently, no data Available
When is Xvivo Perfusion AB’s upcoming earnings report date?
Xvivo Perfusion AB’s upcoming earnings report date is Oct 24, 2024 which is 15 days ago.
How were Xvivo Perfusion AB’s earnings last quarter?
Xvivo Perfusion AB released its earnings results on Jul 12, 2024. The company reported $0.085 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.025.
Is Xvivo Perfusion AB overvalued?
According to Wall Street analysts Xvivo Perfusion AB’s price is currently Overvalued.
Does Xvivo Perfusion AB pay dividends?
Xvivo Perfusion AB does not currently pay dividends.
What is Xvivo Perfusion AB’s EPS estimate?
Xvivo Perfusion AB’s EPS estimate is $0.07.
How many shares outstanding does Xvivo Perfusion AB have?
Xvivo Perfusion AB has 31,499,470 shares outstanding.
What happened to Xvivo Perfusion AB’s price movement after its last earnings report?
Xvivo Perfusion AB reported an EPS of $0.085 in its last earnings report, beating expectations of $0.06. Following the earnings report the stock price went up 20.742%.
Which hedge fund is a major shareholder of Xvivo Perfusion AB?
Currently, no hedge funds are holding shares in XVIPF
---
Xvivo Perfusion AB Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$45.03 (-7.06% Downside)
$45.03 (-7.06% Downside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
58.18%
12-Months-Change
Fundamentals
Return on Equity
6.88%
Trailing 12-Months
Asset Growth
29.63%
Trailing 12-Months
Company Description
Xvivo Perfusion AB
Xvivo Perfusion AB is a medical technology company which develops and markets innovative system solutions for the preservation and evaluation of donated organs outside the body awaiting transplantation. The company supply transplantation clinics worldwide with advanced technological products for the preservation and evaluation of lungs.
---
XVIPF Company Deck
---
XVIPF Earnings Call
Q2 2024
0:00 / 0:00
---
Technical Analysis
---